Ablynx News Today

Ablynx (OTCMKTS:ABLYF – Get Rating) and Immunovant (NASDAQ:IMVT – Get Rating) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations. Institutional & Insider Ownership 32.8% of Immunovant shares are owned by […]

Sanofi Ventures led a $4 million seed financing in i20 last year. (Sanofi) Sanofi has teamed up with i2O Therapeutics to create oral nanobody-based medicines. The partners will use i2O’s platform for protecting peptides and proteins to end the need for nanobodies to be given via intravenous or subcutaneous injections. Nanobodies are therapeutic proteins based on single-domain antibody fragments. Like antibodies, the molecules are typically administered via injections, but advocates of the mod...